drugset / Trial / NCT06270030
Safety, Tolerability and Pharmacokinetics of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Chinese With Presbyopia
RandomizedParallel-groupSingle-blindTreatment
Summary
Phase I Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LNZ101 and LNZ100 Ophthalmic Solutions in Chinese Healthy Adult Subjects with Presbyopia
Timeline
- Start
- 2024-03-04
- Primary completion
- 2024-04-10
- Completion
- 2024-04-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aceclidine | Small molecule | — | Other |
| Subject | Brimonidine | Small molecule | — | Other |